Hepatocellular carcinoma patients highly and specifically expressing XAGE-1 exhibit prolonged survival

Por GONG, LEI, PENG, JIRUN, CUI, ZHUQINGQING, CHEN, PENGCHENG, HAN, HUI, ZHANG, DAFANG, LENG, XISHENG
Publicado em 2010

Proteomic Expression Signature Distinguishes Cancerous and Non-Malignant Tissues in Hepatocellular Carcinoma

Por Lee, Nikki P., Chen, Lei, Lin, Marie C., Tsang, Felice H., Yeung, Chun, Peng, Jirun, Leng, Xisheng, Beretta, Laura, Sun, Stella, Day, Philip J., Luk, John M.
Publicado no J Proteome Res (2009)

Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial

Por Chen, Zhangjing, Wu, Jufang, Zhang, Yingyuan, Wei, Junming, Leng, Xisheng, Bi, Jianwei, Li, Rong, Yan, Lunan, Quan, Zhiwei, Chen, Xiaoping, Yu, Yunsong, Wu, Zhiyong, Liu, Dawei, Ma, Xiaochun, Maroko, Robert, Cooper, Angel
Publicado em 2010

Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker

Por Chen, Lei, Ho, David W. Y., Lee, Nikki P. Y., Sun, Stella, Lam, Brian, Wong, Kwong-Fai, Yi, Xin, Lau, George K., Ng, Eddy W. Y., Poon, Terence C. W., Lai, Paul B. S., Cai, Zongwei, Peng, Jirun, Leng, Xisheng, Poon, Ronnie T. P., Luk, John M.
Publicado em 2010